Development of personalized molecular therapy for acute myeloid leukemia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|17|1|20-29

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.17, Iss.1, 2016-01, pp. : 20-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategy for Incorporating Molecular and Cytogenetic Markers into Acute Myeloid Leukemia Therapy

By Frattini Mark G.   Maslak Peter G.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 10, 2008-11 ,pp. : 995-1002

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Optimizing Therapy for Acute Myeloid Leukemia

By Kohrt Holbrook E.   Coutre Steven E.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 10, 2008-11 ,pp. : 1003-1016

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Editorial (Thematic Issue: Toward Personalized Treatment for Acute Myeloid Leukemia)

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 1, 2016-01 ,pp. : 4-5

Bentham Science Publishers

Access to resources Recommend Favorite

New Developments of Differentiation Therapy of Acute Myeloid Leukemia

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 14, Iss. 2, 2017-04 ,pp. : 86-105

Bentham Science Publishers

Access to resources Recommend Favorite

Deregulation of the Mitochondrial Apoptotic Machinery and Development of Molecular Targeted Drugs in Acute Myeloid Leukemia

By  

Current Cancer Drug Targets, Vol. 8, Iss. 3, 2008-05 ,pp. : 207-222

Bentham Science Publishers

Access to resources Recommend Favorite